ArticleMolecular therapy oncolytics2021

Novel two-chain structure utilizing KIRS2/DAP12 domain improves the safety and efficacy of CAR-T cells in adults with r/r B-ALL.

Ming Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.